Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03648372
Title A Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PK) of TAK-981 in Adult Participants With Metastatic Solid Tumors or Lymphomas
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Millennium Pharmaceuticals, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of California San Diego Moores Cancer Center La Jolla California 92093 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Barbara Ann Karmanos Cancer Institute Detroit Michigan 48201 United States Details
HealthPartners Cancer Care Center - Regions Hospital Saint Paul Minnesota 55101 United States Details
University Hospitals Seidman Cancer Center Cleveland Ohio 44106 United States Details
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Froedtert and the Medical College of Wisconsin Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field